GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

JCR Pharmaceuticals Co 4552.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

496

+1.64%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥40.32bn

FY2017FY2026

Net income

¥2.18bn

FY2017FY2026

Free cash flow

−¥11.56bn

FY2017FY2026

Shareholders' equity

¥46.94bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥40.32bn¥33.07bn¥42.87bn¥34.34bn¥51.08bn¥30.09bn¥24.78bn¥23.16bn¥20.59bn¥18.09bn
Gross profit¥30.06bn¥21.55bn¥31.25bn¥25.46bn¥40.62bn¥22.27bn¥16.88bn¥16.59bn¥14.47bn¥12.35bn
Research and development¥16.76bn¥15.43bn¥11.23bn¥8.80bn¥7.17bn¥5.36bn¥6.00bn¥4.35bn¥4.21bn¥4.07bn
Operating income¥431.0m−¥6.84bn¥7.53bn¥4.99bn¥19.93bn¥8.27bn¥3.25bn¥4.97bn¥3.79bn¥2.36bn
Net income¥2.18bn−¥4.76bn¥5.51bn¥3.77bn¥14.51bn¥6.89bn¥2.68bn¥3.71bn¥3.07bn¥1.86bn
Diluted earnings per share17.86-39.0045.2130.23116.2055.4821.5729.9424.7715.15

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥109.24bn¥105.45bn¥102.67bn¥94.94bn¥97.13bn¥73.78bn¥48.12bn¥42.96bn¥38.74bn¥36.39bn
Cash and short-term investments¥14.01bn¥13.20bn¥18.76bn¥13.28bn¥30.98bn¥26.26bn¥11.19bn¥8.50bn¥6.11bn¥5.81bn
Total liabilities¥61.88bn¥58.01bn¥46.19bn¥42.52bn¥46.05bn¥35.23bn¥15.54bn¥12.08bn¥11.21bn¥8.80bn
Debt¥53.89bn¥38.28bn¥23.43bn¥22.87bn¥18.14bn¥18.14bn¥8.76bn¥5.73bn¥5.66bn¥4.84bn
Shareholders' equity¥46.94bn¥47.04bn¥56.18bn¥52.16bn¥50.88bn¥38.38bn¥32.39bn¥30.68bn¥27.34bn¥27.59bn
Shares outstanding122m122m122m125m125m124m124m124m124m123m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations−¥135.0m−¥5.49bn¥9.31bn−¥5.50bn¥9.29bn¥10.34bn¥4.93bn¥3.90bn¥3.13bn¥2.65bn
Capital spending−¥11.43bn−¥9.89bn−¥1.53bn−¥7.65bn−¥11.33bn−¥4.78bn−¥4.84bn−¥895.0m−¥922.0m−¥1.55bn
Free cash flow−¥11.56bn−¥15.37bn¥7.79bn−¥13.15bn−¥2.04bn¥5.56bn¥89.0m¥3.01bn¥2.21bn¥1.10bn
Dividends paid−¥2.44bn−¥2.50bn−¥2.50bn−¥2.74bn−¥2.17bn−¥1.08bn−¥989.0m−¥834.0m−¥748.0m−¥699.3m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥9.70bn¥9.97bn¥8.99bn¥12.79bn¥8.57bn¥7.19bn¥9.22bn¥8.51bn
Gross profit¥7.45bn¥6.59bn¥6.51bn¥10.79bn¥6.17bn¥2.82bn¥6.50bn¥6.37bn
Operating income−¥2.10bn¥116.0m−¥1.99bn¥2.95bn−¥644.0m−¥5.94bn−¥60.0m−¥327.0m
Net income−¥1.91bn¥435.0m¥34.0m¥2.26bn−¥546.0m−¥4.18bn¥115.0m−¥891.0m
Diluted earnings per share-15.643.570.2818.49-4.48-34.290.94-7.31
Total assets¥106.40bn¥109.24bn¥113.31bn¥109.06bn¥107.34bn¥105.45bn¥105.52bn¥104.62bn
Cash and short-term investments¥9.66bn¥14.01bn¥15.64bn¥15.62bn¥13.18bn¥13.20bn¥15.51bn¥18.27bn
Debt¥42.09bn¥53.89bn¥37.76bn¥40.10bn¥28.16bn¥38.16bn¥20.24bn¥28.41bn
Shareholders' equity¥43.22bn¥46.94bn¥46.33bn¥48.16bn¥46.26bn¥47.04bn¥52.58bn¥56.70bn

Financial ratios

Data as of 12 Sept 2026

FY2026FY2025FY2024FY2023FY2022FY2021
Gross margin74.6%65.2%72.9%74.1%79.5%74.0%
Operating margin1.1%-20.7%17.6%14.5%39.0%27.5%
Net margin5.4%-14.4%12.8%11.0%28.4%22.9%
Return on equity4.6%-10.1%9.8%7.2%28.5%18.0%
Return on assets2.0%-4.5%5.4%4.0%14.9%9.3%
Free cash flow yield18.1%7.0%17.4%3.4%32.3%23.8%
Revenue growth21.9%-22.9%24.8%-32.8%69.8%21.4%
Earnings growth-145.8%-186.4%46.0%-74.0%110.5%157.4%
Current ratio1.16x1.16x1.91x1.34x1.48x1.67x
Debt to equity1.15x0.81x0.41x0.44x0.36x0.47x
Equity ratio43.0%44.6%54.7%54.9%52.4%52.0%
Interest coverage1.08x-44.14x87.58x113.36x443.00x196.90x
R&D as a share of sales41.6%46.7%26.2%25.6%14.0%17.8%
Buybacks as a share of market value-0.0%-0.1%2.4%0.0%-0.5%-0.1%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.5%6.0%8.7%
Operating income-55.8%-44.6%-14.9%
Net income-16.7%-20.6%2.0%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin70.3%71.9%73.9%72.2%
Operating margin-8.7%4.1%14.8%15.1%
Net margin-3.5%4.5%12.1%12.3%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings29.6-18.313.438.814.540.1113.074.047.087.6
Price to sales1.62.61.74.34.19.212.211.97.09.0

Dividends and splits

Per share, in the currency the company pays

Paid for 26 years. Last went ex-dividend on 29 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year10.0030.0020.0020.0020.0017.008.758.00
  • 4-for-1 split · 29 Sept 2020

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.